Turnstone Biologics Corp. (TSBX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TSBX currently has 23.1M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 0.44% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 09, 2025 |
10-Q filing | 23.1M shares outstanding |
23M | 0 |
| Mar 31, 2025 |
10-K filing | 23.0M shares outstanding |
23M | 0 |
| Nov 12, 2024 |
10-Q filing | 23.0M shares outstanding |
23M | 0 |
| Aug 14, 2024 |
10-Q filing | 23.0M shares outstanding |
23M | 0 |
| May 13, 2024 |
10-Q filing | 23.0M shares outstanding |
23M | 0 |
| Mar 22, 2024 |
10-K filing | 23.1M shares outstanding |
23M | 0 |
| Nov 13, 2023 |
10-Q filing | 23.1M shares outstanding |
23M | 0 |
| Sep 01, 2023 |
10-Q filing | 22.8M shares outstanding |
23M | 0 |
| Jul 17, 2023 |
S-1/A filing: This S-1/A filing discusses voting rights, liquidation preferences, rights and preferences of common stockholders, potential conflicts of interest, and the possibility of stock price decline due to substantial sales of common stock. It also mentions Takeda's non-binding indication of interest to purchase shares in the offering and lock-up agreements. |
21M | 0 |
| Jun 26, 2023 |
S-1/A filing: This S-1/A filing discusses voting rights, liquidation preferences, and rights and preferences of common stock holders. It also mentions an option for underwriters to purchase additional shares and restrictions on sales of similar securities by the company and its insiders for 180 days. |
N/A | 0 |
| Jun 12, 2023 |
S-1 filing: This is an S-1 filing detailing voting rights, liquidation preferences, and restrictions on the sale of common stock by insiders for 180 days after the prospectus date, with exceptions for certain transfers. It also mentions an option for underwriters to purchase additional shares. |
N/A | 0 |